Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2026-01-22 @ 9:42 AM
Study NCT ID:
NCT00297232
Status:
TERMINATED
Last Update Posted:
2016-07-15
First Post:
2006-02-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Natalizumab (Tysabri) Re-Initiation of Dosing
Sponsor:
Biogen
Organization: